CaMKII beta Antibody (D-6): sc-376828. Western blot analysis of CaMKIIβ expression in untreated HeLa (A), chemically-treated HeLa (B, C), untreated K-562 (D) and chemically-treated K-562 (E) whole cell lysates. Detection reagent used: m-IgGκ BP-HRP: sc-516102. β-Actin (C4): sc-47778 used as loading control. Detection reagent used: m-IgG Fc BP-HRP: sc-525409.
Not CRISPR data: the image illustrates antibody quality for visualizing CRISPR experiment results.
CaMKII beta Antibody (D-6): sc-376828. Western blot analysis of CaMKIIβ expression in untreated HeLa (A), chemically-treated HeLa (B, C), untreated K-562 (D) and chemically-treated K-562 (E) whole cell lysates. Detection reagent used: m-IgGκ BP-HRP: sc-516102. β-Actin (C4): sc-47778 used as loading control. Detection reagent used: m-IgG Fc BP-HRP: sc-525409.
Not CRISPR data: the image illustrates antibody quality for visualizing CRISPR experiment results.
20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
CaMKII beta Double Nickase Plasmid (h) consists of a pair of plasmids each encoding a D10A mutated Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed to knockout gene expression with greater specificity than its CRISPR/Cas9 KO counterpart
Paired gRNA sequences are offset by approximately 20 bp to allow for specific Cas9-mediated double nicking of the genomic DNA, which mimics a DSB
One plasmid in the pair contains a puromycin-resistance gene for selection; the other plasmid in the pair contains a GFP marker to visually confirm transfection
CaMKII beta Double Nickase Plasmid (h) and CaMKII beta Double Nickase Plasmid (h2) encode distinct paired gRNA designs targeting CAMK2B. One or both designs may be available
Following transfection, gene knockout efficiency can be assayed by WB, IF or IHC using antibody: CaMKII beta Antibody (K-19): sc-100366